Schonfeld Group Holdings’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Schonfeld Group Holdings’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$586K	Buy	+11,389	New	+$552K	0.37%	80

Other funds holding PTLA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Schonfeld Group Holdings's PTLA Position: Q4 2015 in Review

Schonfeld Group Holdings opened a new position in Portola Pharmaceuticals, Inc. (PTLA) in Q4 2015: 11,389 shares worth $586K. The stake represents 0.37% of the portfolio and ranks #80 among its holdings.

190 funds tracked by Wall St. Rank hold PTLA as of Q4 2015.

Schonfeld Group Holdings held 11,389 shares of Portola Pharmaceuticals, Inc. worth $586K as of Q4 2015.
Portola Pharmaceuticals, Inc. was a new Schonfeld Group Holdings position in Q4 2015.
Portola Pharmaceuticals, Inc. made up 0.37% of Schonfeld Group Holdings's portfolio in Q4 2015, its #80 holding.
190 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2015.

Based on Schonfeld Group Holdings's 13F filing for Q4 2015, filed 12 Feb 2016.